港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

584.227

-3.532-0.60%

涨家数：12

跌家数：19

平家数：3

市盈率：- -

高：589.700

开：587.671

低：576.889

收：587.759

成交量：6,860.00万

成交额：12.69亿

市值：3,573.73亿

流通市值：3,214.95亿

数据加载中...

总览新闻资讯

每日卖空追踪 | 同源康医药-B 12月18日卖空量成交2万股，卖空比例为1.46%

“港股BD之王”拿大单，金额或超11亿美元！股价不涨反跌，公司：大部分收入明年确认

非执行董事郭华清增持科济药业(02171)3万股每股作价14.98港元

A股三大指数表现分化沪指全日收涨0.16% 医药商业、航天航空等板块涨幅居前

奥布替尼SLE临床试验突破背后诺诚健华单产品依赖隐忧｜创新药观察

华夏时报网

港股异动 | 先瑞达医疗-B(06669)午后涨近5% 公司继续与波士顿科学深化战略合作

智通财经网

创新药概念逆市上扬石药集团(01093)午后升幅扩至近6%

《股市简讯》中国康宁杰瑞制药一度涨4.5%，抗癌药获美国FDA突破性疗法认定

刚刚，直线拉升！美国，传来大消息！

体内CAR-T赛道白热化：盘点国内19家核心企业管线全景图

康宁杰瑞(09966.HK)JSKN003治疗卵巢癌等获FDA突破性疗法认定

阿斯达克财经

微创医疗(00853)涨逾9% 此前宣布整合心通医疗等心脏科业务

人福医药被ST：收到近千万元罚单，“麻醉一哥”卸下包袱？

加科思－Ｂ(01167)股价上升5.029%，现价港币$8.98

阿斯达克财经

启明医疗－Ｂ(02500)股价上升8.19%，现价港币$2.51

阿斯达克财经

科济药业-B于12月17日斥资673.7万港元回购46.6万股

献血年龄拟延长至65周岁；同仁堂澄清：未持有南极磷虾油事件中涉及的四川健康药业任何股权丨医药早参

每日经济新闻

和铂医药拿下超10亿美元BD交易，远大医药创新RDC在美获批临床，步长制药、九典制药撤回药品注册申请

华昊中天医药-B(02563)：优替德隆治疗乳腺癌脑转移美国关键临床研究首例患者用药

一品红出售参股公司股权，涉核心痛风创新药股价大跌

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":584.22656,"timestamp":1766045292012,"preClose":587.75903,"halted":0,"volume":68600038,"delay":0,"changeRate":-0.00601,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-3.532471,"latestTime":"12-18 16:00:00","open":587.6708,"high":589.70044,"low":576.88855,"amount":1269057381,"amplitude":0.021798,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1766021400000,1766030400000],[1766034000000,1766044800000]],"pbRate":4.97274,"peRate":-40.922669,"turnoverRate":0.002491,"increases":10,"decrements":21,"flats":2,"marketCap":357373288832,"floatMarketCap":321494630240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":589.70044,"amplitude":0.021798,"preClose":587.75903,"low":576.88855,"pbRate":"4.97274","latestPrice":584.22656,"volume":68600038,"delay":0,"open":587.6708,"prevYearClose":331.1933,"prevWeekClose":614.11,"prevMonthClose":632.157,"prevQuarterClose":752.859,"fiveDayClose":595.939,"twentyDayClose":610.919,"sixtyDayClose":730.007,"secType":"PLATE","market":"HK","turnoverRate":0.002491,"peRate":-40.922669,"marketCap":357373288832,"floatMarketCap":321494630240,"timestamp":1766045292012,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":12,"down":19,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592997683","title":"每日卖空追踪 | 同源康医药-B 12月18日卖空量成交2万股，卖空比例为1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592997683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592997683?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 16:30","pubTimestamp":1766046628,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月18日，跌0.36%，卖空量成交2万股，较上一交易日减少20%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163422a6b1b434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163422a6b1b434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2592736909","title":"“港股BD之王”拿大单，金额或超11亿美元！股价不涨反跌，公司：大部分收入明年确认","url":"https://stock-news.laohu8.com/highlight/detail?id=2592736909","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592736909?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 15:49","pubTimestamp":1766044151,"startTime":"0","endTime":"0","summary":"在今年先后宣布与阿斯利康、日本制药巨头大冢制药达成合作后，和铂医药-B（02142.HK）再度宣布与百时美施贵宝（BMS）的合作。12月17日，和铂医药发布公告称，公司与百时美施贵宝达成长期全球战略合作及许可协议，双方将共同研发新一代多特异性抗体疗法。根据协议条款，和铂医药将与百时美施贵宝合作推进及加速多特异性抗体发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595419049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","BMS","BK1583","BK1574","BK4080","02142","BK4231","BK1161"],"gpt_icon":0},{"id":"2592897845","title":"非执行董事郭华清增持科济药业(02171)3万股 每股作价14.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592897845","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592897845?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 15:35","pubTimestamp":1766043318,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，12月15日，非执行董事郭华清增持科济药业(02171)3万股，每股作价14.98港元，总金额为44.94万港元。增持后最新持股数目约为2.24亿股，持股比例为38.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02171","BK1585","BK1161","BK1587"],"gpt_icon":0},{"id":"2592920158","title":"A股三大指数表现分化 沪指全日收涨0.16% 医药商业、航天航空等板块涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2592920158","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592920158?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 15:11","pubTimestamp":1766041876,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股三大指数表现分化，沪指低开后回升，创业板指、深成指震荡走低。截至收盘，沪指涨0.16%，深成指跌1.29%，创业板指跌2.17%。沪深两市成交额1.66万亿，较上一个交易日缩量1557亿。总体上看，个股涨多跌少，两市近2900只个股上涨。盘面上看，医药商业、航天航空、商业百货等板块涨幅居前；电池、汽车、电网设备等板块受压居前。财信证券认为，短期内，在适当控制仓位的前提下，把握好市场结构性机会，中长期而言，在“反内卷”改善上市公司业绩、居民储蓄资产入市、全球流动性缓和、科技产业趋势加持下，2026年A股“慢牛”行情大概率延续。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971814","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399001","BK1161","BK1515","000300.SH","159967","000905.SH","510300","399006","510880","BK1574","512880","512510","000001","000688.SH","515890"],"gpt_icon":0},{"id":"2592201369","title":"奥布替尼SLE临床试验突破背后 诺诚健华单产品依赖隐忧｜创新药观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2592201369","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592201369?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 15:03","pubTimestamp":1766041380,"startTime":"0","endTime":"0","summary":"12月15日，生物医药公司诺诚健华宣布，其核心产品奥布替尼用于治疗系统性红斑狼疮（SLE）的IIb期临床研究达到主要终点，并已获国家药品监督管理局批准开展Ⅲ期临床试验。这一进展虽标志着该药在开拓自身免疫疾病这一巨大新市场的道路上迈出关键一步，但其通往成功商业化的道路仍布满不确定性，或将面临来自临床试验、市场竞争及公司战略的多重严峻挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183595356395.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595356395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","159992","SLE","06978","09969","688428","BK1161","BK1574","BK4077"],"gpt_icon":0},{"id":"2592927112","title":"港股异动 | 先瑞达医疗-B(06669)午后涨近5% 公司继续与波士顿科学深化战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2592927112","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592927112?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 14:41","pubTimestamp":1766040067,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先瑞达医疗-B午后涨近5%，截至发稿，涨4.36%，报13.17港元，成交额304.16万港元。消息面上，先瑞达与波士顿科学旗下公司签署了总合作协议及总服务协议。这是继2023年首次签约后，双方将继续深化战略合作，延续并拓展此前的成功伙伴关系，共同协定未来三年内，双方在产品全球商业化、产品制造服务、产品研发等领域开展的一系列合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0048584097.USD","LU1791710582.SGD","LU1720051017.SGD","LU1366192091.USD","LU1720051108.HKD","LU0823417653.USD","LU0251132253.USD","BSX","LU0267386448.USD","LU0345769631.USD","SGXZ57979304.SGD","IE0002141913.USD","LU2362540622.SGD","IE0009355771.USD","LU2324357040.USD","BK4588","LU1989764664.SGD","BK1587","LU2491050154.USD","LU0823417737.USD","LU2506951875.HKD","LU1023059063.AUD","BK4082","LU0114720955.EUR","LU1791710400.SGD","BK1100","LU0353189763.USD","LU2265009873.SGD","LU0266013472.USD","LU0238689110.USD","06669","LU0077335932.USD","LU0823416689.USD","LU1057294990.SGD","SG9999013999.USD","LU1718418525.SGD","LU1804176565.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0225283273.USD","IE00B2B36J28.USD","LU1153585028.USD","LU0353189680.USD","LU0432979614.USD","LU0528227936.USD","LU0345769128.USD","BK1574","IE00BJJMRZ35.SGD","BK4585","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2592513924","title":"创新药概念逆市上扬 石药集团(01093)午后升幅扩至近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513924","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592513924?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 13:21","pubTimestamp":1766035316,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念逆市上扬，石药集团 升5.98%，药明生物升1.97%，药明合联升1.56%，先声药业升1.51%，药明康德升1.28%。开源证券指出，当前纳入医保+商保的创新药大多处于未放量以及低基数阶段，随着医保支持创新药的政策红利持续释放，我们认为纳入双目录的创新药收入有望快速提升，患者有望持续受益，同时相关创新药企也随之迎来弹性增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","02269","159992","LU1688375341.USD","LU1794554557.SGD","LU0052750758.USD","BK1574","LU0181495838.USD","SG9999002463.SGD","LU0140636845.USD","02268","06978","BK1515","LU0856984785.SGD","LU1242518857.USD","LU3063872942.SGD","LU1807302812.USD","BK1589","LU1152091754.HKD","LU1226287792.SGD","IE00B031HY20.USD","BK1583","LU0307460666.USD","IE0008369823.USD","LU1328277881.USD","LU1226287875.USD","LU1242518931.SGD","LU1813983027.USD","IE00BZ08YS42.EUR","LU0348825331.USD","LU1008478684.HKD","IE00B5MMRT66.SGD","BK1191","LU0315179316.USD","LU0588546209.SGD","02096","SG9999002562.SGD","LU0320764599.SGD","02359","IE00BZ08YT58.USD","IE00B543WZ88.USD","LU1046422090.SGD","LU0039217434.USD","IE00BZ08YR35.GBP","LU0348735423.USD","LU0572944931.SGD","01093","LU0051755006.USD","LU0456827905.SGD","LU0501845795.SGD"],"gpt_icon":0},{"id":"2592921994","title":"《股市简讯》中国康宁杰瑞制药一度涨4.5%，抗癌药获美国FDA突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2592921994","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592921994?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 12:59","pubTimestamp":1766033944,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康宁杰瑞制药一度涨4.5%，抗癌药获美国FDA突破性疗法认定* 中国生物科技公司--康宁杰瑞制药9966.HK周四早盘一度升4.5%，早市收高2.6%。* 该公司此前公告称，JSKN003已获美国食品药品监督管理局授予突破性疗法认定，用于治疗既往接受过贝伐珠单抗治疗的晚期或转移性人表皮生长因子受体2有表达铂耐药复发性上皮性卵巢癌、原发性腹膜癌或输卵管癌成年患者。* 康宁杰瑞制药今年迄今暴涨200%，同期恒生指数.HSI上扬26.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL4T3XO0BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2592383924","title":"刚刚，直线拉升！美国，传来大消息！","url":"https://stock-news.laohu8.com/highlight/detail?id=2592383924","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592383924?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 12:05","pubTimestamp":1766030729,"startTime":"0","endTime":"0","summary":"今早，A股和港股创新药皆由低位直线拉升，华人健康20%涨停，塞力医疗、重药控股涨停，新诺威、多瑞医药、新天药业、南新制药等表现强势。创新药大消息北京时间2025年12月18日凌晨，参议院官网显示，搭载修订版《生物安全法案》的美国2026财年国防授权法案以77票赞成，20票反对结果获得参议院通过，后续将送往白宫，由美国总统签署后立即生效。据新浪，近日先瑞达医疗与全球器械设备龙头公司美国波士顿科学，签署合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218120529a6b0bbca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218120529a6b0bbca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06669","BK1587","BK1100","BK1574"],"gpt_icon":0},{"id":"2592838922","title":"体内CAR-T赛道白热化：盘点国内19家核心企业管线全景图","url":"https://stock-news.laohu8.com/highlight/detail?id=2592838922","media":"求实药社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592838922?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 12:02","pubTimestamp":1766030559,"startTime":"0","endTime":"0","summary":"跨国药企重磅加注，国内Biotech加速推进，体内CAR-T已成细胞治疗领域的热门赛道。这项颠覆性技术旨在解决传统CAR-T高成本、长周期的痛点，并进一步拓展血液瘤、实体瘤及自免疾病适应症。纵观国内研发格局，体内CAR-T正呈现出“技术路线多元化”与“临床验证加速化”的双重特征。从进展来看，IIT已成为当前验证体内CAR-T安全性与有效性的主战场。2025年3月完成首例患者给药，进入临床阶段，是国内较早进入体内CAR临床阶段的企业之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218134128a459f8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218134128a459f8ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2592929694","title":"康宁杰瑞(09966.HK)JSKN003治疗卵巢癌等获FDA突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2592929694","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592929694?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 12:01","pubTimestamp":1766030460,"startTime":"0","endTime":"0","summary":"康宁杰瑞公布，JSKN003已获美国食品药品监督管理局授予突破性疗法认定，用于治疗既往接受过贝伐珠单抗治疗的晚期或转移性人表皮生长因子受体2有表达铂耐药复发性上皮性卵巢癌、原发性腹膜癌或输卵管癌成年患者。此前，JSKN003已获FDA批准开展一项治疗不限HER2表达水平的PROC的II期临床试验，且分别在PROC和结肠直肠癌上获国家药监局药品审评中心授予BTD，在PROC上获FDA授予快速通道资格认定并在胃╱胃食管结合部癌上获FDA授予孤儿药资格认定。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201218151509539_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201218151509539_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1491195/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2592926816","title":"微创医疗(00853)涨逾9% 此前宣布整合心通医疗等心脏科业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2592926816","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592926816?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 11:25","pubTimestamp":1766028316,"startTime":"0","endTime":"0","summary":"金吾财讯 | 微创医疗(00853)早盘股价冲高，并向上突破30天线，截至发稿，报11.06港元，涨9.07%，成交额2.41亿港元。消息面上，12月15日，微创通过整合旗下心脏科业务，心通医疗(02160)与微创心律管理策略合并议案正式获股东大会审议通过，并购将推动微创医疗旗下结构性心脏病与心律管理两大核心业务板块的深度整合。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971789","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1585","BK1589","BK1100","02160","BK1574","00853"],"gpt_icon":0},{"id":"2592925195","title":"人福医药被ST：收到近千万元罚单，“麻醉一哥”卸下包袱？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592925195","media":"新京报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592925195?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 10:58","pubTimestamp":1766026680,"startTime":"0","endTime":"0","summary":"\n                                                未及时披露非经营性资金占用、未及时披露关联交易、财报存在虚假记载、时任控股股东隐瞒关联关系，人福医药及前控股股东当代科技被列出“四宗罪”。                                                [全文]\n","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2025/12/17/5665475523824920241.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2025/12/17/5665475523824920241.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1765978956129223.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1765978956129223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK1515","BK1574","BK1161","159938","09939"],"gpt_icon":0},{"id":"2592923460","title":"加科思－Ｂ(01167)股价上升5.029%，现价港币$8.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923460","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592923460?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 10:18","pubTimestamp":1766024280,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在上午10:18比前收市价上升5.029%，现股价为港币$8.98。至目前为止，今日最高价为$8.98，而最低价为$8.5。总成交量为136.59万股，总成交金额为港币$1.198千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR251218459/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2592992355","title":"启明医疗－Ｂ(02500)股价上升8.19%，现价港币$2.51","url":"https://stock-news.laohu8.com/highlight/detail?id=2592992355","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592992355?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 10:04","pubTimestamp":1766023440,"startTime":"0","endTime":"0","summary":"[上升股]启明医疗－Ｂ(02500) 股价在上午10:04比前收市价上升8.19%，现股价为港币$2.51。至目前为止，今日最高价为$2.51，而最低价为$2.35。总成交量为92.9万股，总成交金额为港币$225.402万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR251218406/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","02500","BK1583","BK1100"],"gpt_icon":0},{"id":"2592911942","title":"科济药业-B于12月17日斥资673.7万港元回购46.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911942","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592911942?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 08:36","pubTimestamp":1766018160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　科济药业-B（02171）发布公告，于2025年12月17日斥资673.7万港元回购46.6万股。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-12-18/doc-inhceprr6885420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","BK1585","02171","BK1587"],"gpt_icon":0},{"id":"2592391941","title":"献血年龄拟延长至65周岁；同仁堂澄清：未持有南极磷虾油事件中涉及的四川健康药业任何股权丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2592391941","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592391941?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 07:13","pubTimestamp":1766013193,"startTime":"0","endTime":"0","summary":"NO.1献血年龄拟延长至65周岁献血法修订草案公开征求意见12月17日，国家卫生健康委发布公告，就献血法（修订草案征求意见稿）面向社会公开征求意见。献血者年龄从提倡18周岁至55周岁，修订为提倡18周岁至65周岁的公民在符合健康要求的情况下自愿献血。血站对献血者每次采集全血不得超过400毫升，两次采集全血间隔期从不少于6个月修订为不少于90天。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183594629549.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183594629549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0086","600085","BK1515","LU1688375341.USD","BK1574","09939","BK0097","BK1161","BK0012","BK0028","159938","BK0196","BK0239","BK0188","BK0183","BK0113"],"gpt_icon":0},{"id":"2592191726","title":"和铂医药拿下超10亿美元BD交易，远大医药创新RDC在美获批临床，步长制药、九典制药撤回药品注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2592191726","media":"谈医说药","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592191726?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 22:44","pubTimestamp":1765982654,"startTime":"0","endTime":"0","summary":"因恩格列净片需进一步完善申报资料，公司决定申请撤回该药品的上市许可注册申请，待完善相关研究后将择期重新提交申请。GPN01530是远大医药首款获得FDA批准开展临床研究的自研RDC产品，本次临床获批是远大医药“Go Global”战略的重要里程碑，彰显了公司在前沿核药技术平台建设、国际化临床开发与注册申报等方面的综合实力。截至本公告披露日，经查询国家药品监督管理局官网，国内暂无猴痘疫苗获批上市使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224900a4576cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224900a4576cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","00512","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2592691845","title":"华昊中天医药-B(02563)：优替德隆治疗乳腺癌脑转移美国关键临床研究首例患者用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2592691845","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592691845?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 21:29","pubTimestamp":1765978175,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B 发布公告,本公司全资美国子公司Biostar Pharma, Inc.已完成其一项重要海外临床研究的首例患者给药：UTD1联合卡培他滨治疗HER2阴性乳腺癌脑转移美国关键注册临床研究。优替德隆也被美国FDA授予治疗乳腺癌脑转移的孤儿药资格。晚期乳腺癌患者约20–50%会发生脑部转移。优替德隆有望改变现状，为这类患者带来新的治疗手段和生存希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","09939","BK1574","02563","159938"],"gpt_icon":0},{"id":"2592894918","title":"一品红出售参股公司股权，涉核心痛风创新药股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2592894918","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592894918?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 21:14","pubTimestamp":1765977240,"startTime":"0","endTime":"0","summary":"目前一品红通过全资子公司瑞腾生物（香港）有限公司持有Arthrosi 13.45%的股权。尽管一品红明确表示，交易将产生积极影响并同步推出股份回购方案，但公司股价连续大幅下挫，创近半年市值新低。上述交易需Arthrosi股东会批准，交易完成后，一品红将不再持有Arthrosi股权。事实上，一品红早已提前锁定AR882的国内核心权益。今年上半年，一品红子公司瑞奥生物以自有资金680万美元受让控股子公司广州瑞安博少数股东Arthrosi持有的15.25%股权。","market":"sh","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2025/12/wangl8820251217215312835718.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2025/12/wangl8820251217215312835718.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1765977295169934.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1765977295169934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0239","300723","06978","BK1161","BK1574","159992"],"gpt_icon":0}],"pageSize":20,"totalPage":33,"pageCount":1,"totalSize":645,"code":"91000000","status":"200"}]}}